The effects of kisspeptin on β‐cell function, serum metabolites and appetite in humans
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aims: To investigate the effect of kisspeptin on glucose‐stimulated insulin secretion and appetite in humans. Materials and methods: In 15 healthy men (age: 25.2 ± 1.1 years; BMI: 22.3 ± 0.5 kg m −2 ), we compared the effects of 1 nmol kg −1 h −1 kisspeptin versus vehicle administration on glucose‐stimulated insulin secretion, metabolites, gut hormones, appetite and food intake. In addition, we assessed the effect of kisspeptin on glucose‐stimulated insulin secretion in vitro in human pancreatic islets and a human β‐cell line (EndoC‐βH1 cells). Results: Kisspeptin administration to healthy men enhanced insulin secretion following an intravenous glucose load, and modulated serum metabolites. In keeping with this, kisspeptin increased glucose‐stimulated insulin secretion from human islets and a human pancreatic cell line in vitro. In addition, kisspeptin administration did not alter gut hormones, appetite or food intake in healthy men. Conclusions: Collectively, these data demonstrate for the first time a beneficial role for kisspeptin in insulin secretion in humans in vivo. This has important implications for our understanding of the links between reproduction and metabolism in humans, as well as for the ongoing translational development of kisspeptin‐based therapies for reproductive and potentially metabolic conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640
Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988 · cited 2×
“The profiles of numerous small molecules (Figure S4) and lipid species (Figure 3) were altered, including lysophosphatidylcholine (LPC 18:2), which was reduced by kisspeptin administration and has previously been shown to be negatively correlated with insulin secretion.(36) All annotated metabolites that significantly…”
BackgroundPlasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917 · cited 1×
“This is consistent with previous data which show that intravenous glucose administration alone does not activate the incretin response mediated by gut hormones.(44) Furthermore, the above studies suggest that GLP-1 and glucagon may act upstream of kisspeptin, whereas in our study we directly administered kisspeptin, w…”
ResultHaffner, S. M., Ralph, D., Saad, M. F., Rewers, M., Mykkänen, L., Selby, J., Howard, G., Savage, P. J., Hamman, R. F., Wegenknecht, L. E., et al. (1996) · Diabetes · doi:10.2337/diab.45.6.742 · Cited by 536
Unique Arrangement of α- and β-Cells in Human Islets of Langerhans
Bosco, D., Armanet, M., Morel, P., Niclauss, N., Sgroi, A., Muller, Y. D., Giovannoni, L., Parnaud, G., & Berney, T. (2010) · Diabetes · doi:10.2337/db09-1177 · Cited by 450
Fu, L.-Y., & van den Pol, A. N. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2098-10.2010 · Cited by 243
Lipotoxicity disrupts incretin-regulated human β cell connectivity
Hodson, D. J., Mitchell, R. K., Bellomo, E. A., Sun, G., Vinet, L., Meda, P., Li, D., Li, W.-H., Bugliani, M., Marchetti, P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68459 · Cited by 210
Self-citationDisposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes
Lorenzo, C., Wagenknecht, L. E., Rewers, M. J., Karter, A. J., Bergman, R. N., Hanley, A. J. G., & Haffner, S. M. (2010) · Diabetes Care · doi:10.2337/dc10-0165 · Cited by 145 · cited 1×
“IVGTT-DI quantifies the ability of the β-cell to counter insulin resistance,(32) with lower baseline IVGTT-DI values independently predicting conversion from normal glucose tolerance or impaired glucose tolerance to type 2 diabetes within 5 years.(32) Therefore, our finding that kisspeptin increases GSIS and IVGTT-DI…”
Cited by
Metabolic regulation of kisspeptin — the link between energy balance and reproduction
Navarro, V. M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0363-7 · Cited by 240
Kisspeptin and Polycystic Ovary Syndrome
Tang, R., Ding, X., & Zhu, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00298 · Cited by 93
Gadgil, M. D., Kanaya, A. M., Sands, C., Chekmeneva, E., Lewis, M. R., Kandula, N. R., & Herrington, D. M. (2022) · The Journal of Nutrition · doi:10.1093/jn/nxac191 · Cited by 16
Self-citation
Metadata
- Authors
- Izzi‐Engbeaya, C., Comninos, A. N., Clarke, S. A., Jomard, A., Yang, L., Jones, S., Abbara, A., Narayanaswamy, S., Eng, P. C., Papadopoulou, D., Prague, J. K., Bech, P., Godsland, I. F., Bassett, P., Sands, C., Camuzeaux, S., Gomez‐Romero, M., Pearce, J. T. M., Lewis, M. R., Holmes, E., Nicholson, J. K., Tan, T., Ratnasabapathy, R., Hu, M., Carrat, G., Piemonti, L., Bugliani, M., Marchetti, P., Johnson, P. R., Hughes, S. J., James Shapiro, A. M., Rutter, G. A., & Dhillo, W. S.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2018-08-16
- Volume
- 20
- Issue
- 12
- Pages
- 2800-2810
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2881018690
- Cited by
- 94
- References
- 8
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.